Literature DB >> 214689

Stimulation of human lymphocytes by cytomegalovirions and dense bodies.

I Sarov, A M Larsen, I Heron, H K Andersen.   

Abstract

Lymphocytes from healthy adult individuals were examined for their ability to incorporate thymidine in the presence of cytomegalovirus (CMV) and dense bodies. It was found that lymphocytes from donors with antibodies to CMV were stimulated to incorporate thymidine-14C both by preparation of CMV and CMV dense bodies. Lymphocytes from CMV seronegative donors did not respond. Dilution experiments and the dose-response curve indicate that the stimulation induced by the dense body preparation was not caused by the small amounts of contaminating CMV particles. These results indicate that in healthy human adults there is a correlation between CMV seropositivity and in vitro lymphocyte transformation, induced by either CMV or by dense bodies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214689     DOI: 10.1007/bf02121137

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  19 in total

1.  A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS.

Authors:  G PLUMMER; M BENYESH-MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  HUMAN CYTOMEGALOVIRUS INFECTION. ELECTRON MICROSCOPIC AND HISTOCHEMICAL CHANGES IN CULTURES OF HUMAN FIBROBLASTS.

Authors:  B H RUEBNER; T HIRANO; R J SLUSSER; D N MEDEARIS
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

3.  ULTRASTRUCTURAL, CYTOCHEMICAL, AND MICROCHEMICAL OBSERVATIONS ON CYTOMEGALOVIRUS (SALIVARY GLAND VIRUS) INFECTION OF HUMAN CELLS IN TISSUE CULTURE.

Authors:  M H MCGAVRAN; M G SMITH
Journal:  Exp Mol Pathol       Date:  1965-02       Impact factor: 3.362

4.  Adult cytomegalovirus inclusion retino-uveitis.

Authors:  L C Chumbley; D M Robertson; T F Smith; R J Campbell
Journal:  Am J Ophthalmol       Date:  1975-11       Impact factor: 5.258

5.  Oncogenic transformation of human embryo lung cells by human cytomegalovirus.

Authors:  K M Geder; R Lausch; F O'Neill; F Rapp
Journal:  Science       Date:  1976-06-11       Impact factor: 47.728

6.  Ultrastructural study on the sequence of human cytomegalovirus infection in human diploid cells.

Authors:  Y Iwasaki; T Furukawa; S Plotkin; H Koprowski
Journal:  Arch Gesamte Virusforsch       Date:  1973

Review 7.  Herpesviruses and oncogenesis.

Authors:  G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

8.  Complement-fixing and virus-neutralizing antibodies in cytomegalovirus infection as measured against homologous and heterologous antigen.

Authors:  H K Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

9.  Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus.

Authors:  T Albrecht; F Rapp
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

View more
  5 in total

1.  Mitogenic activity in human embryonic fibroblasts early after infection by human cytomegalovirus.

Authors:  N Takehara; K Ryoke; T Kurimura
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

2.  In vitro stimulation of lymphocytes by different strains of cytomegalovirus.

Authors:  L Gärtner; J A Wilhelm; R Czieschnek
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

3.  Cytomegalovirus (CMV): specific lymphokine production in congenital CMV infection.

Authors:  R C Gehrz; T E Leonard
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

4.  Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression.

Authors:  S Pepperl; J Münster; M Mach; J R Harris; B Plachter
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Comparison of in vitro lymphocyte proliferations induced by cytomegalovirus-infected human fibroblasts and cell-free cytomegalovirus.

Authors:  J Schirm; H W Roenhorst; T H The
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.